Addressing this autoimmune disorder characterized by thrombosis or pregnancy morbidity coupled with persistent antiphospholipid antibodies involves identifying and mitigating thrombosis risk factors.
Expanding access to naloxone, sterile syringes, and HIV preexposure prophylaxis can help prevent negative consequences of drug use and reduce inequities in overdose-related morbidity and mortality.